DEVELOPMENT OF REAGENTS FOR APPLICATION OF AT-211 AND BI-213 TO TARGETED RADIOTHERAPY OF CANCER

$280,514FY2008Department of EnergyDOE

University Of Washington, Seattle WA

Investigators